Summary:
This is a 64 week long study with about 19 clinic visits and weekly telephone contacts comparing the safety and efficacy of an investigational medication to a currently marketed insulin.
Qualified Participants Must:
• Be 18 years of age or older
•
Diagnosed with Type 2 Diabetes
•
Be treated with long acting insulin
Qualified Participants May Receive:
All study-related medication, study-related care, a glucometer and strips at no cost. Qualified participants will be paid $50/completed visit at the end of their study participation.